STOCK TITAN

Medtronic (MDT) director granted 2,111 shares; 207 withheld for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Medtronic plc director Lidia Fonseca reported routine equity compensation activity. She received an award of 2,111 ordinary shares in the form of restricted stock units that vest on the one-year anniversary of the award date.

Upon vesting of previously granted restricted stock units, 207 shares were withheld to cover taxes at a price of $81.90 per share. After these transactions, she directly owns 7,644 Medtronic ordinary shares, which includes 65 shares acquired through dividend reinvestment since her last report.

Positive

  • None.

Negative

  • None.
Insider Fonseca Lidia
Role null
Type Security Shares Price Value
Tax Withholding Ordinary Shares 207 $81.90 $17K
Grant/Award Ordinary Shares 2,111 $0.00 --
Holdings After Transaction: Ordinary Shares — 7,644 shares (Direct, null)
Footnotes (1)
  1. Represents an award of restricted stock units that vest on the one-year anniversary of the award date. Includes 65 shares acquired through dividend reinvestment since the last report filed by the reporting person. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
Restricted stock unit award 2,111 shares Award of ordinary shares via RSUs vesting after one year
Tax-withheld shares 207 shares Shares withheld for payment of taxes on RSU vesting
Tax-withholding price $81.90 per share Price applied to 207 shares withheld for taxes
Shares owned after transactions 7,644 shares Direct Medtronic ordinary share holdings following reported activity
Dividend reinvestment shares 65 shares Shares acquired through dividend reinvestment since last report
restricted stock units financial
"Represents an award of restricted stock units that vest on the one-year anniversary"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend reinvestment financial
"Includes 65 shares acquired through dividend reinvestment since the last report"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
withheld for payment of taxes financial
"Represents shares withheld for payment of taxes upon the vesting of restricted stock units"
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
tax-withholding disposition financial
"transaction_action: tax-withholding disposition"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fonseca Lidia

(Last)(First)(Middle)
C/O MEDTRONIC
710 MEDTRONIC PARKWAY

(Street)
MINNEAPOLIS MINNESOTA 55432

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares04/27/2026A2,111(1)A$07,851(2)D
Ordinary Shares04/28/2026F207(3)D$81.97,644D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents an award of restricted stock units that vest on the one-year anniversary of the award date.
2. Includes 65 shares acquired through dividend reinvestment since the last report filed by the reporting person.
3. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
Remarks:
/s/ Patricia Walesiewicz, attorney-in-fact04/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Medtronic (MDT) director Lidia Fonseca report on this Form 4?

She reported routine equity compensation activity, including a grant of 2,111 restricted stock units that settle as ordinary shares and a tax-related share withholding. These transactions update her direct ownership position in Medtronic following standard compensation and vesting processes.

How many Medtronic (MDT) shares were granted to Lidia Fonseca?

She was granted 2,111 ordinary shares in the form of restricted stock units. According to the disclosure, these restricted stock units will vest on the one-year anniversary of the award date, reflecting a typical annual equity compensation grant for a company director.

Why were 207 Medtronic (MDT) shares disposed of in this filing?

The 207 shares reflect tax-withholding, not an open-market sale. They were withheld to pay taxes upon the vesting of previously granted restricted stock units, at a price of $81.90 per share, which is a common administrative mechanism for covering tax obligations on equity awards.

How many Medtronic (MDT) shares does Lidia Fonseca own after these transactions?

After the reported grant and tax withholding, she directly owns 7,644 Medtronic ordinary shares. This total includes 65 shares that were acquired through dividend reinvestment since her prior report, as noted in the filing’s footnotes for additional context.

What are the vesting terms of Lidia Fonseca’s new Medtronic restricted stock units?

The new award consists of restricted stock units that vest on the one-year anniversary of the award date. Upon vesting, these units are settled in ordinary shares, aligning director compensation with Medtronic’s share performance over the vesting period.

Does this Medtronic (MDT) Form 4 indicate any open-market buying or selling by Lidia Fonseca?

No open-market purchases or sales are reported. The filing shows a grant of restricted stock units at no cost and a tax-withholding disposition of 207 shares, which is an administrative step tied to vesting, not a discretionary trade in the market.